Legislation: batch B — IL IN KS KY LA MA MD ME MI MN

Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>

legislation/us/states/ky/2026rs/sb-77.md

@@ -0,0 +1,102 @@
+---
+type: "Bill"
+title: "AN ACT relating to ibogaine research in the Commonwealth."
+description: "Create new sections of KRS Chapter 218A to define terms; establish the ibogaine research and intellectual property fund to be administered by the Department of Agriculture for the purpose of allowing the department to enter a public-private partnership with a drug developer to conduct a clinical drug development trial or trials related to the use of ibogaine for the treatment of opioid use disorder, co-occurring substance use disorder, or any other neurological or mental health condition for which ibogaine demonstrates efficacy; establish requirements for the department related to how it contracts with a drug developer related to ibogaine research and intellectual property; appropriate $21 million from the opioid abatement trust fund to the ibogaine research and intellectual property development fund in fiscal year 2026-2027 and in fiscal year 2027-2028; APPROPRIATION; EMERGENCY."
+jurisdiction: "us/states/ky"
+legislature: "Kentucky General Assembly"
+session: "2026RS"
+identifier: "SB 77"
+citation: "Kentucky SB 77 (2026RS)"
+classification: ["bill"]
+subjects: ["Agriculture", "Appropriations", "Budget And Financial Administration", "Drugs And Medicines", "Effective Dates", "Emergency", "Funds", "Opioids", "Public Health", "State Agencies"]
+status: "enacted"
+primary_sponsors: ["A. Reed", "D. Carroll", "D. Douglas", "L. Tichenor", "S. Funke Frommeyer", "S. Madon", "S. Rawlings"]
+version_count: 3
+action_count: 35
+vote_count: 4
+first_action: "2026-01-13T05:00:00+00:00"
+last_action: "2026-04-14T04:00:00+00:00"
+source: "openstates"
+source_identifier: "ocd-bill/0332a489-c847-4ae5-a711-5e4e6e0ddd72"
+source_url: "https://apps.legislature.ky.gov/record/26RS/sb77.html"
+source_hash: "d6056c03297c2ac4addf3c28a5f480757d251b21f5794cb90ba0031f88269a02"
+vintage: "2026-07-01"
+source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
+retrieved_at: "2026-07-06"
+confidence: "reported"
+tags: ["legislation", "bill", "us-ky"]
+---
+
+# Kentucky SB 77 (2026RS) — AN ACT relating to ibogaine research in the Commonwealth.
+
+Create new sections of KRS Chapter 218A to define terms; establish the ibogaine research and intellectual property fund to be administered by the Department of Agriculture for the purpose of allowing the department to enter a public-private partnership with a drug developer to conduct a clinical drug development trial or trials related to the use of ibogaine for the treatment of opioid use disorder, co-occurring substance use disorder, or any other neurological or mental health condition for which ibogaine demonstrates efficacy; establish requirements for the department related to how it contracts with a drug developer related to ibogaine research and intellectual property; appropriate $21 million from the opioid abatement trust fund to the ibogaine research and intellectual property development fund in fiscal year 2026-2027 and in fiscal year 2027-2028; APPROPRIATION; EMERGENCY.
+
+## Version chain
+
+The bill's text revisions, in order — the diff chain from filing to enrollment.
+
+1. **Introduced** (filed) — [source](https://apps.legislature.ky.gov/recorddocuments/bill/26RS/sb77/orig_bill.pdf)
+2. **Acts Chapter 158** (committee substitute) — [source](https://apps.legislature.ky.gov/law/acts/26RS/documents/0158.pdf)
+3. **Current/Final** (committee substitute) — [source](https://apps.legislature.ky.gov/recorddocuments/bill/26RS/sb77/bill.pdf)
+
+## Votes
+
+- Pass — **82–8** (pass) · upper
+- Veto Override — **77–18** (pass) · upper
+- PASS SB 77 w/ SCS 1, SCA 1 (T) — **35–2** (pass) · upper
+- OVERRIDE VETO FINAL PASSAGE SB 77 — **31–6** (pass) · upper
+
+## Sponsors
+
+- A. Reed — primary (person)
+- D. Carroll — primary (person)
+- D. Douglas — primary (person)
+- L. Tichenor — primary (person)
+- S. Funke Frommeyer — primary (person)
+- S. Madon — primary (person)
+- S. Rawlings — primary (person)
+
+## Timeline
+
+The legislative action history — every referral, reading, and vote.
+
+- **2026-01-13T05:00:00+00:00** introduced in Senate `introduction`
+- **2026-01-13T05:00:00+00:00** to Committee on Committees (S) `referral-committee`
+- **2026-03-09T04:00:00+00:00** to Health Services (S) `referral-committee`
+- **2026-03-11T04:00:00+00:00** reported favorably, 1st reading, to Calendar with Committee Substitute (1) and Committee Amendment (1-title) `committee-passage`
+- **2026-03-12T04:00:00+00:00** 2nd reading, to Rules `reading-2`
+- **2026-03-12T04:00:00+00:00** posted for passage in the Regular Orders of the Day for Friday, March 13 2026
+- **2026-03-13T04:00:00+00:00** 3rd reading, passed 35-2 with Committee Substitute (1) and Committee Amendment (1-title) `passage, reading-3`
+- **2026-03-17T04:00:00+00:00** received in House
+- **2026-03-17T04:00:00+00:00** to Committee on Committees (H) `referral-committee`
+- **2026-03-20T04:00:00+00:00** to Veterans, Military Affairs, & Public Protection (H) `referral-committee`
+- **2026-03-24T04:00:00+00:00** reported favorably, 1st reading, to Calendar `committee-passage`
+- **2026-03-25T04:00:00+00:00** 2nd reading, to Rules `reading-2`
+- **2026-04-01T04:00:00+00:00** taken from Rules
+- **2026-04-01T04:00:00+00:00** placed in the Orders of the Day
+- **2026-04-01T04:00:00+00:00** 3rd reading, passed 82-8 `passage, reading-3`
+- **2026-04-01T04:00:00+00:00** received in Senate
+- **2026-04-01T04:00:00+00:00** enrolled, signed by President of the Senate `passage`
+- **2026-04-01T04:00:00+00:00** enrolled, signed by Speaker of the House `passage`
+- **2026-04-01T04:00:00+00:00** delivered to Governor
+- **2026-04-13T04:00:00+00:00** Vetoed `executive-veto`
+- **2026-04-14T04:00:00+00:00** received in Senate
+- **2026-04-14T04:00:00+00:00** to Rules (S) `referral-committee`
+- **2026-04-14T04:00:00+00:00** posted for passage for consideration of Governor's veto
+- **2026-04-14T04:00:00+00:00** veto overridden `veto-override-passage`
+- **2026-04-14T04:00:00+00:00** passed 31-6 `passage`
+- **2026-04-14T04:00:00+00:00** received in House
+- **2026-04-14T04:00:00+00:00** to Rules (H) `referral-committee`
+- **2026-04-14T04:00:00+00:00** taken from Rules (H)
+- **2026-04-14T04:00:00+00:00** posted for consideration of Governor's veto
+- **2026-04-14T04:00:00+00:00** veto overridden `veto-override-passage`
+- **2026-04-14T04:00:00+00:00** passed 77-18 `passage`
+- **2026-04-14T04:00:00+00:00** received in Senate
+- **2026-04-14T04:00:00+00:00** enrolled, signed by President of the Senate `passage`
+- **2026-04-14T04:00:00+00:00** enrolled, signed by Speaker of the House `passage`
+- **2026-04-14T04:00:00+00:00** delivered to Secretary of State (Acts Ch. 158) `became-law`
+
+## Source
+
+OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/0332a489-c847-4ae5-a711-5e4e6e0ddd72`. Confidence: reported (aggregated from official Kentucky legislature records).
+